Kohwa Biotech (002022.SZ): the complement C1q detection kit (latex immunoturbidimetry method) has obtained a medical device registration certificate.

China Fortune Finance News APP reported that Kehua Bio (002022.SZ) has issued an announcement stating that the company has received a medical device registration certificate (in vitro diagnostic reagents) issued by the Shanghai Food and Drug Administration. The product is the "Complement C1q Assay Kit (Latex Enhanced Turbidimetric Immunoassay)", which is intended for in vitro quantitative determination of complement C1q content in human serum and plasma for medical institutions.